Modern product engineering requires the production of highly accurate digital simulations, allowing engineers to create ...

OpenAI's rebrand balances the technical and the emotional by updating its logo and centering a new typeface called OpenAI ...

The stock market extended its winning streak on Wednesday, closing firmer as investors seemed to have already priced in the ...

Boston Dynamics Wednesday announced a partnership designed to bring improved reinforcement learning to its electric Atlas ...

David R. Epstein, a director at Tempus AI , Inc. (NASDAQ:TEM), recently sold 370 shares of the company's Class A Common Stock. The shares were sold on February 3, 2025, at an average price of $53.31 ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

TD Cowen analyst Dan Brennan reinstated coverage of Tempus AI (TEM) with a Buy rating and price target of $74, up from $58, following the ...

Bullish option flow detected in tempus AI ( TEM) Inc Class A with 20,081 calls trading, 2x expected, and implied vol increasing over 2 points to 111.52%. 2/7 weekly 60 calls and 2/7 weekly 58 calls ...

Coming to the latest development around Olivia, the investors are optimistic, evident from the stock surge last week.

Tempus AI connects with over 2,500 institutions to collect real-time clinical data on millions of cancer patients. The company is able to use AI to derive diagnostic testing from this testing.

Tempus AI, Inc. TEM recently unveiled olivia ... Following the announcement, shares of the company moved north 5.9% to $50.45 on Wednesday. In the past six months, TEM shares have gained 32.6 ...

confidence in the company’s long-term potential is evident. The broader market is recognizing the transformative role AI plays in healthcare, and Tempus stands at the forefront of this innovation.